Shares of Mediclinic International PLC (LON:MDC) have been assigned an average rating of “Hold” from the nine research firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is GBX 707.38 ($9.52).

Several analysts recently commented on MDC shares. Jefferies Group raised Mediclinic International to a “buy” rating and raised their target price for the stock from GBX 550 ($7.40) to GBX 616 ($8.29) in a report on Thursday, November 30th. Credit Suisse Group raised their target price on Mediclinic International from GBX 265 ($3.57) to GBX 305 ($4.10) and gave the stock a “neutral” rating in a report on Thursday, October 26th. Macquarie reaffirmed a “neutral” rating and set a GBX 660 ($8.88) target price on shares of Mediclinic International in a report on Thursday, October 26th. Citigroup reaffirmed a “neutral” rating on shares of Mediclinic International in a report on Tuesday, October 24th. Finally, J P Morgan Chase & Co lowered Mediclinic International to a “neutral” rating and dropped their target price for the stock from GBX 898 ($12.09) to GBX 733 ($9.87) in a report on Thursday, October 19th.

Mediclinic International (MDC) traded up GBX 10.97 ($0.15) during trading on Thursday, reaching GBX 590.50 ($7.95). The company had a trading volume of 1,971,963 shares, compared to its average volume of 2,550,000. Mediclinic International has a 12-month low of GBX 495.40 ($6.67) and a 12-month high of GBX 890.18 ($11.98).

The firm also recently disclosed a dividend, which will be paid on Monday, December 18th. Shareholders of record on Thursday, December 7th will be issued a GBX 3.20 ($0.04) dividend. This represents a yield of 0.61%. The ex-dividend date of this dividend is Thursday, December 7th.

ILLEGAL ACTIVITY NOTICE: This article was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this article can be read at https://www.americanbankingnews.com/2017/12/07/mediclinic-international-plc-mdc-receives-consensus-rating-of-hold-from-analysts.html.

Mediclinic International Company Profile

Mediclinic International plc is an international private healthcare provider. The Company’s segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services. It has interest in Spire Healthcare, a United Kingdom-based private healthcare company.

Analyst Recommendations for Mediclinic International (LON:MDC)

Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with MarketBeat.com's FREE daily email newsletter.